+ Watch GWAY
on My Watchlist
The company has been beat up by a missed earnings report. It's now 5% off from where it was before it's most recent earnings were released. This makes the price very attractive.The company has two new catalysts to grow. First, it recently inked a deal with Walgreen to put its software in each of their stores. Second, Cerner certified its software and insured that their software will be compatible with one another's.Because the company operates on a subscription revenue basis, the increase in revenue from Walgreen and Cerner users will not be just a one-time spike. As the company becomes more profitable it should easily continue improving.
This small-cap provides IT software and services to ambulatory healthcare providers. It's a nice niche that will continue to see steady growth.
These folks are in medical-records filing technology, a business with a small number of very fierce competitors [think EXSR and ATHN and SXCI]. Still, there's room enough in this big pool for small fry. Moreover, hospitals and doctors have got to get right with tech record-keeping whatever its security risks.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions